(Q34002121)

30 July 2017

Radiotherapy in the treatment of patients with unresectable extrahepatic cholangiocarcinoma (English)

1 reference

Adaptive radiation therapy

30 July 2017

0 references

0 references

4

Junzo Chino

1 reference

30 July 2017

A Paiman Ghafoori

1

1 reference

30 July 2017

John W Nelson

2

1 reference

30 July 2017

Christopher G Willett

3

1 reference

30 July 2017

Douglas S Tyler

5

1 reference

30 July 2017

Herbert I Hurwitz

6

1 reference

30 July 2017

Hope E Uronis

7

1 reference

30 July 2017

Michael A Morse

8

1 reference

30 July 2017

Robert W Clough

9

1 reference

30 July 2017

Brian G Czito

10

1 reference

30 July 2017

language of work or name

English

0 references

publication date

23 September 2010

1 reference

International Journal of Radiation Oncology Biology Physics

30 July 2017

1 reference

30 July 2017

81

1 reference

30 July 2017

3

1 reference

30 July 2017

654-659

1 reference

Multimodality Treatment With Helical Tomotherapy Intensity Modulated Radiotherapy, Capecitabine, and Photodynamic Therapy is Feasible and Well Tolerated in Patients With Hilar Cholangiocarcinoma

30 July 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4121739

Chemoradiation and brachytherapy in biliary tract carcinoma: long-term results

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4121739

Chemoradiation may prolong survival of patients with non-bulky unresectable extrahepatic biliary carcinoma. A retrospective analysis.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4121739

Gallbladder and biliary tract carcinoma: A comprehensive update, Part 2.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4121739

A review and update on cholangiocarcinoma

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4121739

Cancers of the gallbladder and biliary ducts.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4121739

Limitations of conventional doses of chemoradiation for unresectable biliary cancer

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4121739

Cholangiocarcinoma of the extrahepatic bile ducts

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4121739

Role of radiotherapy, in particular intraluminal brachytherapy, in the treatment of proximal bile duct carcinoma

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4121739

External radiation therapy and transcatheter iridium in the treatment of extrahepatic bile duct carcinoma

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4121739

The impact of radiation dose in combined external beam and intraluminal Ir-192 brachytherapy for bile duct cancer

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4121739

"Natural history" of unresected cholangiocarcinoma: patient outcome after noncurative intervention

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4121739

Combined 5-fluorouracil and supervoltage radiation therapy of locally unresectable gastrointestinal cancer

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4121739

Pancreatic cancer. Adjuvant combined radiation and chemotherapy following curative resection

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4121739

The role of radiotherapy in the treatment of bile duct carcinoma

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4121739

Role of radiation after operative palliation in cancer of the proximal bile ducts

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4121739

The role of radiation therapy in cancer of the extra-hepatic biliary system: an analysis of thirteen patients and a review of the literature of the effectiveness of surgery, chemotherapy and radiotherapy

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4121739

Brachytherapy and percutaneous stenting in the treatment of cholangiocarcinoma: a prospective randomised study.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4121739

Intensity-modulated radiotherapy in treatment of pancreatic and bile duct malignancies: toxicity and clinical outcome

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4121739

Intraluminal low-dose-rate 192Ir brachytherapy combined with external beam radiotherapy and biliary stenting for unresectable extrahepatic bile duct carcinoma.

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4121739

Length and quality of survival following external beam radiotherapy combined with expandable metallic stent for unresectable hilar cholangiocarcinoma.

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4121739

Carcinoma of the extrahepatic bile ducts. The University of California at San Francisco experience

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4121739

Intraluminal brachytherapy in the treatment of pancreas and bile duct carcinoma.

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4121739

Combined modality therapy of extrahepatic biliary system cancer

29 October 2018

1 reference

12 December 2020

Analysis of Failure After Curative Irradiation of Extrahepatic Bile Duct Carcinoma

1 reference

12 December 2020

The role of radiotherapy in the management of extrahepatic bile duct cancer: an analysis of 145 consecutive patients treated with intraluminal and/or external beam radiotherapy

1 reference

12 December 2020

Malignant biliary duct obstruction: long-term experience with Gianturco stents and combined-modality radiation therapy

1 reference

12 December 2020

Primary cancers of extrahepatic biliary passages

1 reference

12 December 2020

Extrahepatic biliary system cancer: an update of a combined modality approach

1 reference

12 December 2020

Therapy of locally unresectable pancreatic carcinoma: a randomized comparison of high dose (6000 rads) radiation alone, moderate dose radiation (4000 rads + 5-fluorouracil), and high dose radiation + 5-fluorouracil: The Gastrointestinal Tumor Study

1 reference

12 December 2020

Combined external beam radiotherapy and intraluminal high dose rate brachytherapy on bile duct carcinomas

1 reference

12 December 2020

10.1016/J.IJROBP.2010.06.018

Identifiers

DOI

1 reference

30 July 2017

1 reference

30 July 2017

1 reference